NCT00015626View on ClinicalTrials.gov

A Clinical Trial to Prevent the Complications of Insulin Resistance (Including Type-2 Diabetes)

PHASE2CompletedINTERVENTIONAL

Enrollment

300

Participants

Timeline

Start Date

Not specified

Conditions

Insulin ResistanceDiabetes Mellitus

Interventions

DRUG

Metformin

PROCEDURE

skin biopsy

BEHAVIORAL

diet and exercise

DRUG

pioglitazone

DRUG

rosiglitazone

Trial Locations (1)

10021

Cornell University, New York

All Listed Sponsors

lead

National Center for Research Resources (NCRR)

NIH